Notizie AIOM – anno XVII – Pagina 66

11 Aprile 2019

CDC Issues Clarification on Guideline for Prescribing Opioids for Chronic Pain in Patients With Cancer and Sickle Cell Disease

April 9, 2019 - ASCO, the American Society of Hematology (ASH), and the National Comprehensive Cancer Network® (NCCN®) are pleased to acknowledge receipt of a key clarification from the Centers for Disease Control and Prevention (CDC) on prescribing opioids to manage ...
Leggi tutto

11 Aprile 2019

Lenalidomide/Rituximab Data Published as FDA Weighs Non-Hodgkin Lymphoma Approval

April 9, 2019 - The R2 regimen of lenalidomide plus rituximab significantly reduced the risk of disease progression or death compared with rituximab alone in patients with relapsed/refractory indolent non-Hodgkin lymphoma, according to results from the pivotal phase III ...
Leggi tutto

9 Aprile 2019

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium

Noninvasive genotyping using plasma cell-free DNA (cfDNA) has the potential to obviate the need for some invasive biopsies in cancer patients while also elucidating disease heterogeneity. We sought to develop an ultra-deep plasma next-generation sequencing (NGS) assay for ...
Leggi tutto

8 Aprile 2019

Sandoz Resubmits Application for Pegfilgrastim Biosimilar

April 5, 2019 - A biologics license application has been resubmitted to the FDA for the pegfilgrastim biosimilar LA-EP2006 to decrease the incidence of infection from febrile neutropenia in patients with nonmyeloid malignancies receiving myelosuppressive anticancer therapy. ...
Leggi tutto

8 Aprile 2019

FDA Approval Sought for Luspatercept for Anemias

April 5, 2019 - A supplemental biologics license application (sBLA) has been submitted to the FDA for luspatercept for the treatment of adult patients with very low- to intermediate-risk myelodysplastic syndrome (MDS)–associated anemia with ring sideroblasts who require ...
Leggi tutto

5 Aprile 2019

New Survey on Utilization Management Practices Reveals Barriers to Care for People With Cancer

April 2, 2019 - "The results of a recently released survey conducted for the American Cancer Society Cancer Action Network (ACS CAN) raise serious concerns about the negative impact that utilization management practices, including prior authorization requirements, are having ...
Leggi tutto

5 Aprile 2019

FDA takes new enforcement actions as part of the agency’s ongoing effort to combat the illegal online sales of opioids

April 2, 2019 - Today the U.S. Food and Drug Administration announced the issuance of two warning letters to operators of websites that illegally market potentially dangerous, unapproved and misbranded opioid medications, including tramadol. The warning letters issued to ...
Leggi tutto

5 Aprile 2019

Statement from FDA Commissioner Scott Gottlieb, M.D., and Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., on FDA’s ongoing scientific investigation of potential safety issue related to seizures reported following e-cigarette use, particularly in youth and young adults

April 3, 2019 - Over the last nearly two years, we’ve spoken often about both the opportunity for e-cigarettes to be an off-ramp for currently addicted adult smokers to completely switch to a potentially less harmful form of nicotine delivery, as well as the tremendous ...
Leggi tutto

5 Aprile 2019

FDA expands approved use of metastatic breast cancer treatment to include male patients

April 4, 2019 - The U.S. Food and Drug Administration today is extending the indication of palbociclib capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic ...
Leggi tutto

5 Aprile 2019

EU recommendations for 2019/2020 seasonal flu vaccine composition

April 1, 2019 - EMA has issued the EU recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2019. Manufacturers of trivalent vaccines for the 2019/2020 season should include ...
Leggi tutto

LAVORIAMO CON

News

LA PREVENZIONE DEL MELANOMA: AL VIA UNA CAMPAGNA NEI COOP.FI

TUMORI: “AIFA APPROVA LA FORMULAZIONE SOTTOCUTANEA E TRE NUOVE INDICAZIONI TERAPEUTICHE DI NIVOLUMAB”

TUMORE AL SENO: METASTASI SI DIFFONDONO COME GOCCE SU UNA SUPERFICIE. LA CAPACITÀ INVASIVA DIPENDE DALLA “FLUIDITÀ” DEL CANCRO

ONE HEALTH FOUNDATION: AL VIA IL PROGETTO IN 36 CENTRI ESTIVI IN ALBANIA. SULLA “NAVE DELLA SALUTE” SVOLTI PIU’ DI 550 TEST E VISITE MEDICHE

AL VIA LA TERZA EDIZIONE DELLA “NAVE DELLA SALUTE” ITALIA-ALBANIA. LA PREVENZIONE SALE A BORDO CON 17 MEDICI SPECIALISTI E 10 AMBULATORI

TOVORAFENIB È LA PRIMA TERAPIA MIRATA APPROVATA IN EUROPA NEL GLIOMA PEDIATRICO DI BASSO GRADO RECIDIVATO O REFRATTARIO, INDIPENDENTEMENTE DAL TIPO DI ALTERAZIONE DI BRAF

TOZORAKIMAB HA SODDISFATTO L’ENDPOINT PRIMARIO DELLO STUDIO DI FASE III MIRANDA NEI PAZIENTI CON BPCO

Notizie AIOM – anno XVII

CDC Issues Clarification on Guideline for Prescribing Opioids for Chronic Pain in Patients With Cancer and Sickle Cell Disease

Lenalidomide/Rituximab Data Published as FDA Weighs Non-Hodgkin Lymphoma Approval

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium

Sandoz Resubmits Application for Pegfilgrastim Biosimilar

FDA Approval Sought for Luspatercept for Anemias

New Survey on Utilization Management Practices Reveals Barriers to Care for People With Cancer

FDA takes new enforcement actions as part of the agency’s ongoing effort to combat the illegal online sales of opioids

Statement from FDA Commissioner Scott Gottlieb, M.D., and Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., on FDA’s ongoing scientific investigation of potential safety issue related to seizures reported following e-cigarette use, particularly in youth and young adults

FDA expands approved use of metastatic breast cancer treatment to include male patients

EU recommendations for 2019/2020 seasonal flu vaccine composition